← All indications
Carcinogenesis
The origin, production or development of cancer through genotypic and phenotypic changes which upset the normal balance between cell proliferation and cell death. Carcinogenesis generally requires a constellation of steps, which may occur quickly or over a period of many years.
Subtype terms (2)
More specific conditions that are subtypes of Carcinogenesis in the MeSH hierarchy.
Drugs by status
Phase 2 trials (3)
Other trials (2)
Organizations
Organization Involved with Phase 2 Indications (12)
- Cancer Prevention Pharmaceuticals, Inc.
- Texas Enterosorbents Incorporated
- National Cancer Institute (NCI)
- National Institute of Environmental Health Sciences (NIEHS)
- University of Pittsburgh
- Johns Hopkins University
- Texas A&M University
- University of Georgia
- Vanderbilt University
- University of Minnesota
- University of Texas, San Antonio
- Qidong Liver Cancer Institute
Organization Involved with Other Experimental Indications (2)